Blood Gas and Electrolyte Analyzer Market Will Register a CAGR of About 8.6% Between 2017 and 2023
Be it incrementing percentage of geriatrics, unhealthy lifestyle, or simply genetically inherited – the prevalence of chronic diseases is getting stronger by the day. However, advancements that medical science has made in the past few decades are efficient at treating chronic conditions such as chronic obstructive pulmonary diseases (COPD), asthma, heart failure, kidney failure, and uncontrolled diabetes – iff diagnosed early. As the healthcare infrastructure improves across emerging economies – the market for blood gas and electrolyte analyzers is expanding....
View full press release